These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23306532)

  • 1. ADAM10 as a biomarker for Alzheimer's disease: a study with Brazilian elderly.
    Manzine PR; de França Bram JM; Barham EJ; do Vale Fde A; Selistre-de-Araújo HS; Cominetti MR; Iost Pavarini SC
    Dement Geriatr Cogn Disord; 2013; 35(1-2):58-66. PubMed ID: 23306532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer's disease.
    Manzine PR; Barham EJ; Vale FA; Selistre-de-Araújo HS; Pavarini SC; Cominetti MR
    Int J Geriatr Psychiatry; 2014 Apr; 29(4):414-20. PubMed ID: 23970375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between mini-mental state examination and platelet ADAM10 expression in Alzheimer's disease.
    Manzine PR; Barham EJ; Vale Fde A; Selistre-de-Araújo HS; Iost Pavarini SC; Cominetti MR
    J Alzheimers Dis; 2013; 36(2):253-60. PubMed ID: 23579328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects.
    Manzine PR; Marcello E; Borroni B; Kamphuis W; Hol E; Padovani A; Nascimento CC; de Godoy Bueno P; Assis Carvalho Vale F; Iost Pavarini SC; Di Luca M; Cominetti MR
    Biomarkers; 2015; 20(3):196-201. PubMed ID: 26220620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients.
    Bram JMF; Talib LL; Joaquim HPG; Sarno TA; Gattaz WF; Forlenza OV
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):963-972. PubMed ID: 29845446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
    Tang K; Hynan LS; Baskin F; Rosenberg RN
    J Neurol Sci; 2006 Jan; 240(1-2):53-8. PubMed ID: 16256140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10.
    Qin W; Ho L; Wang J; Peskind E; Pasinetti GM
    PLoS One; 2009; 4(1):e4183. PubMed ID: 19159013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of α-Secretase ADAM10 in Platelets Along Cognitively Healthy Aging.
    Schuck F; Wolf D; Fellgiebel A; Endres K
    J Alzheimers Dis; 2016; 50(3):817-26. PubMed ID: 26757187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma ADAM10 Levels and Their Association with Alzheimer's Disease Diagnosis in Older Adults with Fewer Years of Formal Education.
    Pelegrini LNC; da Silva VA; Grigoli MM; Vatanabe IP; Manzine PR; Cominetti MR
    Dement Geriatr Cogn Disord; 2024; 53(3):153-161. PubMed ID: 38583419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.
    Colciaghi F; Borroni B; Pastorino L; Marcello E; Zimmermann M; Cattabeni F; Padovani A; Di Luca M
    Mol Med; 2002 Feb; 8(2):67-74. PubMed ID: 12080182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotoninergic antidepressants positively affect platelet ADAM10 expression in patients with Alzheimer's disease.
    Bianco OA; Manzine PR; Nascimento CM; Vale FA; Pavarini SC; Cominetti MR
    Int Psychogeriatr; 2016 Jun; 28(6):939-44. PubMed ID: 26555131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI).
    Bermejo-Bescós P; Martín-Aragón S; Jiménez-Aliaga K; Benedí J; Felici E; Gil P; Ribera JM; Villar AM
    Neurochem Res; 2013 Jul; 38(7):1415-23. PubMed ID: 23575575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease.
    Pereira Vatanabe I; Peron R; Mantellatto Grigoli M; Pelucchi S; De Cesare G; Magalhães T; Manzine PR; Figueredo Balthazar ML; Di Luca M; Marcello E; Cominetti MR
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
    Colciaghi F; Marcello E; Borroni B; Zimmermann M; Caltagirone C; Cattabeni F; Padovani A; Di Luca M
    Neurology; 2004 Feb; 62(3):498-501. PubMed ID: 14872043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal platelet amyloid-β protein precursor (AβPP) metabolism in Alzheimer's disease: identification and characterization of a new AβPP isoform as potential biomarker.
    Jelic V; Hagman G; Yamamoto NG; Teranishi Y; Nishimura T; Winblad B; Pavlov PF
    J Alzheimers Dis; 2013; 35(2):285-95. PubMed ID: 23388171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
    Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K
    FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM10: Biomarker of mild cognitive impairment but not of cognitive frailty.
    Vatanabe IP; Pedroso RV; Manzine PR; Chagas MHN; de Morais Fabrício D; Grigoli MM; Naves MA; Pott-Jr H; Cominetti MR
    Exp Gerontol; 2021 Jul; 149():111303. PubMed ID: 33675901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM10 as a biomarker for Alzheimer's disease: A systematic review.
    Oliveira Monteiro E Pereira de Almeida MP; Valle Pedroso R; Mantellatto Grigoli M; Vicente Silva T; Manzine PR; Cominetti MR
    Rev Neurol (Paris); 2024; 180(1-2):1-11. PubMed ID: 37460331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrochemical magneto-immunoassay for detection of ADAM10 Alzheimer's biomarker using gold nanoparticles as label.
    de Oliveira TR; Manzine PR; Cominetti MR; Leite OD; Faria RC
    Talanta; 2024 Jan; 266(Pt 2):125042. PubMed ID: 37591151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An enzyme-generated fragment of tau measured in serum shows an inverse correlation to cognitive function.
    Henriksen K; Wang Y; Sørensen MG; Barascuk N; Suhy J; Pedersen JT; Duffin KL; Dean RA; Pajak M; Christiansen C; Zheng Q; Karsdal MA
    PLoS One; 2013; 8(5):e64990. PubMed ID: 23717682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.